2,411
Views
1
CrossRef citations to date
0
Altmetric
Articles

Clinical utility of the updated European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and the Mycoses Study Group Education and Research Consortium computed tomography criteria of invasive pulmonary aspergillosis in hematological malignancies

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon

References

  • Vazquez JA, Tovar-Torres MP, Hingwe A, et al. The changing epidemiology of invasive aspergillosis in the non-traditional host: risk factors and outcomes. Pulm Crit Care Med. 2016;1(3):67–71.
  • Cornet M, Fleury L, Maslo C, et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect. 2002;51:288–296.
  • Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol. 2007;139:519–531.
  • Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49(Suppl 1):S7–S12.
  • Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100(13):4358–4366.
  • Kousha M. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–174.
  • Young AY, LeivaJuarez MM, Evans SE. Fungal pneumonia in patients with hematologic malignancy and hematopoietic stem cell transplantation. Clin Chest Med. 2017;38(3):479–491.
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–1376.
  • Michallet M, Bénet T, Sobh M, et al. Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis. 2012;31:991–997.
  • Cattaneo C, Gramegna D, Malagola M, et al. Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome. Leuk Lymphoma. 2019;60(12):3044–3050.
  • Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–e60.
  • Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology. 1996;200:327–331.
  • Brodoefel H, Vogel M, Hebart H, et al. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Am J Roentgenol. 2006;187(2):404–413.
  • Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373–379.
  • Bergeron A, Porcher R, Sulahian A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119(8):1831–1837.
  • He H, Stein MW, Zalta B, et al. Pulmonary infarction: spectrum of findings on multidetector helical CT. J Thorac Imaging. 2006;21:1–7.
  • Loverdos K, Fotiadis A, Kontogianni C, et al. Lung nodules: a comprehensive review on current approach and management. Ann Thorac Med. 2019;14(4):226–238.
  • Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985;157:611–614.
  • Lee YR, Choi YW, Lee KJ, et al. CT halo sign: the spectrum of pulmonary diseases. Brit J Radiol. 2005;78:862–865.
  • Magira EE, Chemaly RF, Jiang Y, et al. Outcomes in invasive pulmonary aspergillosis infections by respiratory viral infections in patients with hematologic malignancies: a case control study. Open Forum Infect Dis. 2019;6(7):ofz247.
  • Light RW. Pleural disease, Vol. 11. 4th ed. Baltimore: Williams and Wilkins; 2001; Pleural effusion secondary to fungal infections, actinomycosis, and nocardiosis. p. 196–203.
  • Nourbakhsh E, Goodman S, Nugent K, et al. Generalized lymphadenopathy secondary to an invasive fungal infection in an apparently healthy patient. Am J Med Sci. 2010;340(1):84–88.
  • Su SS, Zhou Y, Xu H-Y, et al. Invasive aspergillosis presenting as hilar masses with stenosis of bronchus: a case report. World J Clin Cases. 2019;7(22):3832–3837.
  • Collins J. CT signs and patterns of lung disease. Radiol Clin North Am. 2001;39(6):1115–1135.
  • Weisser M, Rausch C, Droll A, et al. Galactomannan does not precede major signs on a pulmonary computerised tomographic scan suggestive of invasive aspergillosis in patients with hematologic malignancies. Clin Infect Dis. 2005;41:1143–1149.